ED:NYSEConsolidated Edison, Inc. Analysis
Data as of 2026-03-30 - not real-time
$113.33
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Consolidated Edison (ED) is trading at $113.33, comfortably above its 20‑day ($112.06), 50‑day ($109.87) and 200‑day ($102.38) moving averages, indicating a short‑term bullish momentum. The RSI sits at 58, suggesting room for further upside, yet the MACD histogram is negative and the signal line is bearish, warning of a possible near‑term pullback. A DCF‑derived fair value of $106.31 places the stock roughly 7% above intrinsic value, and the upside/downside metric is –2.2%, implying the market may be pricing in optimism beyond fundamentals. Revenue growth remains healthy at 9% YoY with a solid gross margin of 53% and operating margin of 18%, but free cash flow is slightly negative and debt‑to‑equity is high at 117%, flagging balance‑sheet pressure. Dividend sustainability looks reassuring: a 3.08% yield, a 60% payout ratio, and a recent board decision to raise the dividend to $0.8875 per share underscore the company’s commitment to income investors. Recent analyst notes from JPMorgan and Morgan Stanley lifted price targets modestly to $113 and $106 respectively, yet both retain a cautious stance, reflecting the mixed valuation signals. Overall, the stock offers a blend of defensive utility exposure and attractive yield, but investors should weigh the modest overvaluation and leverage against the regulated cash‑flow stability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance level of $116.23
- Bearish MACD signal despite bullish trend
- Strong dividend yield supporting demand
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Stable regulated revenue and 9% growth
- High debt load requiring monitoring
- Consistent dividend payments
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Low beta and defensive utility profile
- Attractive dividend yield and payout growth
- Regulated cash‑flow resilience over economic cycles
Key Metrics & Analysis
Financial Health
Revenue Growth8.90%
Profit Margin11.96%
P/E Ratio20.1
ROE8.77%
ROA3.19%
Debt/Equity117.32
P/B Ratio1.7
Op. Cash Flow$4.8B
Free Cash Flow$-145250000
Industry P/E22.9
Technical Analysis
TrendBullish
RSI57.9
Support$108.48
Resistance$116.23
MA 20$112.06
MA 50$109.87
MA 200$102.38
MACDBearish
VolumeDecreasing
Fear & Greed Index67.77
Valuation
Fair Value$106.31
Target Price$110.88
Upside/Downside-2.16%
GradeOvervalued
TypeValue
Dividend Yield3.08%
Risk Assessment
Beta-0.17
Volatility18.26%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.